Customer Feedback: Third-Party COA Results for Tirzepatide, Ipamorelin & TB-500 – June 2026

We are pleased to share another collection of customer-provided Certificates of Analysis (COAs) from Freedom Diagnostics, USA, dated June 8, 2026.

These independent laboratory reports cover three research peptide samples, with the following HPLC purity results:

  • Tirzepatide (5mg) — 99.89% Purity
  • Ipamorelin (5mg) — 99.85% Purity
  • TB-500 (5mg) — 99.78% Purity

All three samples demonstrated reported purity levels above 99.7%, based on HPLC-UV analysis. The reports also include LC-MS analytical identification data and chromatograms.

Customer-Shared Laboratory Reports

[Insert Image 1: Tirzepatide 5mg — 99.89%]

[Insert Image 2: Ipamorelin 5mg — 99.85%]

[Insert Image 3: TB-500 5mg — 99.78%]

Independent Testing & Research Transparency

We appreciate customers who voluntarily share third-party laboratory reports and analytical findings.

At GL-Peptide, we value independent testing, transparent documentation, and batch-specific quality information to support informed laboratory research.

Research Use Only. The reported results apply exclusively to the tested samples. They do not establish clinical safety, efficacy, or the quality of other product batches. Not intended for human consumption.

Leave a Reply

Your email address will not be published. Required fields are marked *